drugset / Trial / NCT02063997
Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether arhalofenate is effective in preventing flares and reducing serum uric acid in gout patients.
Timeline
- Start
- 2014-03
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | 300 mg | — |
| Subject | Arhalofenate | Unknown | 600 mg | — |
| Subject | Arhalofenate | Unknown | 800 mg | — |
| Comparator | Colchicine | Small molecule | 0.6 mg | — |